http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2354962-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ea13e2354b8982e5ae1afe043360d5c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-48
filingDate 2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d7f4de133500751fdeefe008e44ef9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b39c89a566149baea862b91d28c1a4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d305ab9739380bba621faa3387fe0e74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9588efaeda1b6e88161616ea90473d29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d19d58a568106b47a629fac86d0b4fb
publicationDate 2009-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2354962-C1
titleOfInvention Inverse-voltampere method of determining verapamil hydrochloride
abstract FIELD: medicine. n SUBSTANCE: present invention can be used in medicine for determining concentration of verapamil hydrochloride in the blood of patients with heart rhythm disorder and arterial hypertension with the objective of changing the treatment approach. The said method involves electrical concentration of substance on the surface of a glass-carbon electrode for 120 s and electrolysis potential of (+0.05) V on the background of a 0.001 mol/l solution of ammonium nitrate, alkalised by a 0.2 mol/l solution of sodium hydroxide. Polarisation curves are then plotted with a direct current form of potential sweep at a rate of 50 mV/s. Concentration of verapamil is determined from the height of the peak in the potential interval from 0.8 V to 0.95 V, relative a silver chloride electrode. The experimental conditions set for determining concentration of verapamil hydrochloride using an inverse voltampere method allows for more sensitive and rapid determination of the said compounds in aqueous and biological media, and also allow for designing a method of determining content of trace amounts of verapamil hydrochloride in blood plasma and serum. n EFFECT: design of an efficient method of determining verapamil.
priorityDate 2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449391796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57448911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448605289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449188861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448532098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21583978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451438884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6312181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499459

Total number of triples: 43.